Get the Stockscreener App
7.69
3.36%
0.25
After Hours:
7.69
Lensar Inc stock is traded at $7.69, with a volume of 21,779.
It is up +3.36% in the last 24 hours and up +45.09% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
See More
Previous Close:
$7.44
Open:
$7.5
24h Volume:
21,779
Relative Volume:
0.61
Market Cap:
$87.23M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-4.1793
EPS:
-1.84
Net Cash Flow:
$-9.90M
1W Performance:
+5.63%
1M Performance:
+45.09%
6M Performance:
+83.53%
1Y Performance:
+219.09%
1-Day Range:
$7.43
$7.91
1-Week Range:
$7.00
$8.17
52-Week Range:
$2.12
$8.17
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
7.69 | 87.23M | 42.16M | -14.38M | -9.90M | -1.84 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day - The Manila Times
LENSAR CEO to Present at BTIG Ophthalmology Conference, Discuss Laser Cataract Innovation | LNSR Stock News - StockTitan
LENSAR Stock Soars to 52-Week High, Hits $8 Mark By Investing.com - Investing.com Canada
LENSAR Stock Soars to 52-Week High, Hits $8 Mark - Investing.com India
Sintx Technologies (NASDAQ:SINT) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Contrast - Defense World
Trading (LNSR) With Integrated Risk Controls - Stock Traders Daily
LENSAR, Inc. (NASDAQ:LNSR) Sees Significant Decrease in Short Interest - MarketBeat
LENSAR, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Park West Asset Management LLC's Strategic Acquisition in LENSAR Inc - GuruFocus.com
LENSAR, Inc. (NASDAQ:LNSR) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: LENSAR reports strong Q3 growth, eyes continued expansion By Investing.com - Investing.com South Africa
Earnings call: LENSAR reports strong Q3 growth, eyes continued expansion - Investing.com
LENSAR Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
LENSAR stock soars to 52-week high, hits $6.4 amid robust growth - Investing.com Australia
LENSAR shares rise as BTIG lifts target to $10 on strong Q3 results - Investing.com Australia
LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - Yahoo Finance
LENSAR stock soars to 52-week high, hits $6.4 amid robust growth By Investing.com - Investing.com South Africa
LENSAR Inc. Reports Strong Q3 2024 Growth - TipRanks
LENSAR earnings beat by $0.16, revenue topped estimates - Investing.com Canada
LENSAR Reports Third Quarter 2024 Results and Provides Business Update - Marketscreener.com
LENSAR Q3 Revenue Surges 38% as Global System Placements Drive Growth | LNSR Stock News - StockTitan
LENSAR Inc (LNSR) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LENSAR (LNSR) Scheduled to Post Earnings on Thursday - MarketBeat
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - GlobeNewswire
LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost - Simply Wall St
Sanctuary Advisors LLC Makes New Investment in LENSAR, Inc. (NASDAQ:LNSR) - Defense World
How to Take Advantage of moves in (LNSR) - Stock Traders Daily
LENSAR Stock Soars to 52-Week High, Reaching $5.62 By Investing.com - Investing.com Australia
LENSAR Stock Soars to 52-Week High, Reaching $5.62 - Investing.com
Lensar announces more than 1M procedures completed with cataract laser systems - Yahoo Finance
One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems - GlobeNewswire
Brandes Investment Partners LP Raises Stock Holdings in LENSAR, Inc. (NASDAQ:LNSR) - Defense World
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Ascent Group LLC Cuts Stock Position in The Wendy’s Company (NASDAQ:WEN) - Defense World
9,000 Shares in Sun Communities, Inc. (NYSE:SUI) Purchased by MBB Public Markets I LLC - Defense World
LENSAR (NASDAQ:LNSR) and Delcath Systems (NASDAQ:DCTH) Head to Head Contrast - Defense World
Vivani Medical (NASDAQ:VANI) Stock Quotes, Forecast and News Summary - Benzinga
Magnetar Financial LLC Buys Shares of 20,305 Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):